SCHEMBL17526693

SCHEMBL17526693

CCC[C@@H](CCCO)COC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
LMNA P02545 3/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP3A4 P08684 3/20 0.32
ATM Q13315 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PTPN1 P18031 1/20 0.31
USP2 O75604 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
THRB P10828 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17526685 1.00 ALDH1A1 (0.37) ALDH1A1LMNACA12CA1CA2
SCHEMBL17526914 0.94 LMNA (0.40) ALDH1A1LMNACA12CA1CA2
SCHEMBL17526796 0.92 LMNA (0.43) ALDH1A1LMNACA12CA1CA2
SCHEMBL17527040 0.92 LMNA (0.43) ALDH1A1LMNACA12CA1CA2
SCHEMBL19333803 0.86 ALDH1A1 (0.30) ALDH1A1LMNA
SCHEMBL17526647 0.85 ALDH1A1 (0.45) ALDH1A1LMNACA1CA2SMN1; SMN2
SCHEMBL13568618 0.84 CYP3A4 (0.44) ALDH1A1LMNACA12CA1CA2
SCHEMBL14113755 0.84 CYP3A4 (0.44) ALDH1A1LMNACA12CA1CA2
SCHEMBL17526839 0.84 CYP3A4 (0.44) ALDH1A1LMNACA12CA1CA2
SCHEMBL10212062 0.83 CA12 (0.46) CA12CA1CA2CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 ALDH1A1 2376/4885LMNA 3497/4885CA12 2208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.